Tilray PE Ratio 2017-2020 | TLRY

Current and historical p/e ratio for Tilray (TLRY) from 2017 to 2020. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Tilray PE ratio as of July 07, 2020 is 0.00.
Tilray PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2020-07-08 7.58 0.00
2020-03-31 6.88 $-4.59 0.00
2019-12-31 17.13 $-3.18 0.00
2019-09-30 24.74 $-1.37 0.00
2019-06-30 46.56 $-1.21 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.961B $0.167B
Tilray, Inc. is a pharmaceutical company. It develops cannabis based medicines, drugs, drops and oil products. Tilray, Inc. is based in NANAIMO, Canada.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $65.751B 37.31
Takeda Pharmaceutical (TAK) Japan $55.142B 9.66
Astellas Pharma (ALPMY) Japan $29.910B 15.16
Eisai (ESALY) Japan $23.461B 20.34
UCB SA (UCBJF) Belgium $23.292B 0.00
Merck (MKGAF) Germany $16.149B 21.18
Grifols, S.A (GRFS) Spain $12.857B 15.98
Neurocrine Biosciences (NBIX) United States $11.883B 54.92
Catalent (CTLT) United States $11.421B 44.15
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $9.945B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 0.00
Ionis Pharmaceuticals (IONS) United States $8.553B 45.47
IPSEN SA ADR (IPSEY) France $7.290B 0.00
Orion OYJ (ORINY) Finland $6.978B 31.27
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.664B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.021B 9.64
United Therapeutics (UTHR) United States $5.220B 9.89
STADA ARZNEIMI (STDAF) Germany $4.916B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $4.502B 491.56
Nektar Therapeutics (NKTR) United States $4.297B 0.00
Evotec AG (EVTCY) Germany $4.181B 112.67
Hypermarcas (HYPMY) Brazil $3.762B 11.44
FibroGen (FGEN) United States $3.713B 0.00
ChemoCentryx (CCXI) United States $3.637B 0.00
PTC Therapeutics (PTCT) United States $3.602B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.561B 10.53
Pacira BioSciences (PCRX) United States $2.282B 46.70
Cronos Group (CRON) Canada $2.187B 62.70
Sage Therapeutics (SAGE) United States $2.178B 0.00
Corcept Therapeutics (CORT) United States $1.901B 18.85
Xencor (XNCR) United States $1.857B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.722B 0.00
USANA Health Sciences (USNA) United States $1.708B 17.52
Akebia Therapeutics (AKBA) United States $1.697B 0.00
Indivior (INVVY) United States $1.638B 20.33
Ironwood Pharmaceuticals (IRWD) United States $1.620B 12.40
Zogenix (ZGNX) United States $1.526B 0.00
Esperion Therapeutics (ESPR) United States $1.409B 0.00
Karyopharm Therapeutics (KPTI) United States $1.396B 0.00
Heron Therapeutics (HRTX) United States $1.361B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.359B 14.65
Theravance Biopharma (TBPH) Cayman Islands $1.302B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.250B 0.00
Translate Bio (TBIO) United States $1.103B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.009B 45.05
BioCryst Pharmaceuticals (BCRX) United States $0.954B 0.00
ImmunoGen (IMGN) United States $0.841B 0.00
Endo (ENDP) Ireland $0.832B 1.29
Molecular Templates (MTEM) United States $0.659B 0.00
VAXART, INC (VXRT) United States $0.658B 0.00
Radius Health (RDUS) United States $0.652B 0.00
Ardelyx (ARDX) United States $0.623B 0.00
Aerie Pharmaceuticals (AERI) United States $0.619B 0.00
Trillium Therapeutics (TRIL) Canada $0.608B 0.00
Collegium Pharmaceutical (COLL) United States $0.586B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.582B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.566B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.519B 12.55
BioSpecifics Technologies Corp (BSTC) United States $0.490B 19.11
Innate Pharma SA (IPHYF) France $0.476B 0.00
Flexion Therapeutics (FLXN) United States $0.475B 0.00
Siga Technologies (SIGA) United States $0.470B 0.00
DURECT (DRRX) United States $0.425B 0.00
TherapeuticsMD (TXMD) United States $0.416B 0.00
Harpoon Therapeutics (HARP) United States $0.414B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.402B 0.00
Ocular Therapeutix (OCUL) United States $0.401B 0.00
Organogenesis Holdings (ORGO) United States $0.380B 0.00
Calithera Biosciences (CALA) United States $0.373B 0.00
MEI Pharma (MEIP) United States $0.364B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.320B 0.00
Concert Pharmaceuticals (CNCE) United States $0.296B 0.00
PROFOUND MEDICL (PROF) Canada $0.292B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.289B 0.00
Lannett Co Inc (LCI) United States $0.268B 5.88
Oasmia Pharmaceutical AB (OASMY) Sweden $0.249B 0.00
Redhill Biopharma (RDHL) Israel $0.248B 0.00
CASI Pharmaceuticals (CASI) United States $0.229B 0.00
Taiwan Liposome (TLC) Taiwan $0.220B 0.00
Jounce Therapeutics (JNCE) United States $0.215B 5.14
KalVista Pharmaceuticals (KALV) United States $0.212B 0.00
OptiNose (OPTN) United States $0.208B 0.00
Rafael Holdings (RFL) United States $0.208B 0.00
IMV INC (IMV) Canada $0.188B 0.00
Nivalis Therapeutics (ALPN) United States $0.181B 0.00
Nature's Sunshine Products (NATR) United States $0.179B 23.59
Altimmune (ALT) United States $0.174B 0.00
Aquestive Therapeutics (AQST) United States $0.154B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.151B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.125B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.124B 0.00
Champions Oncology (CSBR) United States $0.117B 0.00
CTI BioPharma (CTIC) United States $0.114B 0.00
Otonomy (OTIC) United States $0.110B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.107B 0.00
Recro Pharma (REPH) United States $0.102B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.101B 0.00
MediWound (MDWD) Israel $0.100B 0.00
Onconova Therapeutics (ONTX) United States $0.099B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.099B 0.00
Xeris Pharmaceuticals (XERS) United States $0.098B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.095B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.091B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.091B 0.00
Hemispherx BioPharma (AIM) United States $0.083B 0.00
Sundial Growers (SNDL) Canada $0.083B 0.00
Biomerica (BMRA) United States $0.080B 0.00
Heat Biologics (HTBX) United States $0.076B 0.00
Aclaris Therapeutics (ACRS) United States $0.074B 0.00
SCYNEXIS (SCYX) United States $0.072B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.066B 0.00
Lipocine (LPCN) United States $0.065B 0.00
CV Sciences (CVSI) United States $0.059B 0.00
RENEURON GP (RNUGF) United Kingdom $0.057B 0.00
Addex Therapeutics (ADXN) Switzerland $0.050B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.050B 30.09
Infinity Pharmaceuticals (INFI) United States $0.050B 0.00
PolarityTE (PTE) United States $0.047B 0.00
Natural Alternatives (NAII) United States $0.046B 0.00
IsoRay (ISR) United States $0.043B 0.00
Forward Pharma (FWP) Denmark $0.043B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.040B 0.00
Novan (NOVN) United States $0.040B 0.00
GTx (ONCT) United States $0.040B 0.00
Mannatechorporated (MTEX) United States $0.039B 7.40
Opiant Pharmaceuticals (OPNT) United States $0.039B 83.18
Adamis Pharmaceuticals (ADMP) United States $0.038B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.038B 0.00
Neos Therapeutics (NEOS) United States $0.034B 0.00
AgeX Therapeutics (AGE) United States $0.034B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.033B 0.00
ElectroCore (ECOR) United States $0.033B 0.00
Jaguar Animal Health (JAGX) United States $0.032B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.027B 0.00
India Globalization Capital (IGC) United States $0.022B 0.00
Iterum Therapeutics (ITRM) Ireland $0.022B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.022B 0.00
Flex Pharma (SLRX) United States $0.020B 0.00
Bio-Path Holdings (BPTH) United States $0.019B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.019B 0.00
Regulus Therapeutics (RGLS) United States $0.018B 0.00
ProPhase Labs (PRPH) United States $0.017B 0.00
Can-Fite Biopharma (CANF) Israel $0.016B 0.00
China SXT Pharmaceuticals (SXTC) China $0.016B 0.00
Shineco (TYHT) China $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 32.71
Sonoma Pharmaceuticals (SNOA) United States $0.011B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.011B 0.00
RXi Pharmaceuticals (PHIO) United States $0.010B 0.00
HANCOCK JAFFE (HJLI) United States $0.010B 0.00
Vical (BBI) United States $0.009B 0.00
Midatech Pharma (MTP) United Kingdom $0.009B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00